"Designing Growth Strategies is in our DNA"

Vitiligo Treatment Market Size, Share and Global Trend By Treatment (Topical Treatment, Light Therapy, Surgical Procedures, Others), By Disease Type (Nonsegmental Vitiligo, Segmental Vitiligo), By End User (Hospitals, Aesthetic Clinics, Others) and Geography Forecast, 2024 - 2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI100580

 

Table of Content:

1. Introduction

    1.1. Research Scope

    1.2. Market Segmentation

    1.3. Research Methodology

    1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

    3.1. Market Drivers

    3.2. Market Restraints

    3.3. Market Opportunities

4. Key Insights

    4.1. Prevalence of vitiligo by key countries

    4.2. Pipeline analysis

    4.3. Recent industry developments - mergers & acquisitions

    4.4. Recent developments in R&D

5. Global Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    5.1. Key Findings / Summary

    5.2. Market Analysis, Insights and Forecast – By Treatment

        5.2.1. Topical Treatment

        5.2.2. Light Therapy

        5.2.3. Surgical Procedures

        5.2.4. Others

    5.3. Market Analysis, Insights and Forecast – By Disease Type

        5.3.1. Nonsegmental Vitiligo

        5.3.2. Segmental Vitiligo

    5.4. Market Analysis, Insights and Forecast – By End-user

        5.4.1. Hospitals

        5.4.2. Aesthetic Clinics

        5.4.3. Others

    5.5. Market Analysis, Insights and Forecast – By Region

        5.5.1. North America

        5.5.2. Europe

        5.5.3. Asia pacific

        5.5.4. Latin America

        5.5.5. Middle East & Africa

6. North America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    6.1. Key Findings / Summary

    6.2. Market Analysis – By Treatment

        6.2.1. Topical Treatment

        6.2.2. Light Therapy

        6.2.3. Surgical Procedures

        6.2.4. Others

    6.3. Market Analysis – By Disease Type

        6.3.1. Nonsegmental Vitiligo

        6.3.2. Segmental Vitiligo

    6.4. Market Analysis – By End-user

        6.4.1. Hospitals

        6.4.2. Aesthetic Clinics

        6.4.3. Others

    6.5. Market Analysis – By Country

        6.5.1. U.S.

        6.5.2. Canada

7. Europe Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    7.1. Key Findings / Summary

    7.2. Market Analysis – By Treatment

        7.2.1. Topical Treatment

        7.2.2. Light Therapy

        7.2.3. Surgical Procedures

        7.2.4. Others

    7.3. Market Analysis – By Disease Type

        7.3.1. Nonsegmental Vitiligo

        7.3.2. Segmental Vitiligo

    7.4. Market Analysis – By End-user

        7.4.1. Hospitals

        7.4.2. Aesthetic Clinics

        7.4.3. Others

    7.5. Market Analysis – By Country/Sub-region

        7.5.1. U.K.

        7.5.2. Germany

        7.5.3. France

        7.5.4. Spain

        7.5.5. Italy

        7.5.6. Scandinavia

        7.5.7. Rest of Europe

8. Asia pacific Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    8.1. Key Findings / Summary

    8.2. Market Analysis – By Treatment

        8.2.1. Topical Treatment

        8.2.2. Light Therapy

        8.2.3. Surgical Procedures

        8.2.4. Others

    8.3. Market Analysis – By Disease Type

        8.3.1. Nonsegmental Vitiligo

        8.3.2. Segmental Vitiligo

    8.4. Market Analysis – By End-user

        8.4.1. Hospitals

        8.4.2. Aesthetic Clinics

        8.4.3. Others

    8.5. Market Analysis – By Country/Sub-region

        8.5.1. Japan

        8.5.2. China

        8.5.3. India

        8.5.4. Australia

        8.5.5. Southeast Asia

        8.5.6. Rest of Asia Pacific

9. Latin America Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    9.1. Key Findings / Summary

    9.2. Market Analysis – By Treatment

        9.2.1. Topical Treatment

        9.2.2. Light Therapy

        9.2.3. Surgical Procedures

        9.2.4. Others

    9.3. Market Analysis – By Disease Type

        9.3.1. Nonsegmental Vitiligo

        9.3.2. Segmental Vitiligo

    9.4. Market Analysis – By End-user

        9.4.1. Hospitals

        9.4.2. Aesthetic Clinics

        9.4.3. Others

    9.5. Market Analysis – By Country/Sub-region

        9.5.1. Brazil

        9.5.2. Mexico

        9.5.3. Rest of Latin America

10. Middle East & Africa Vitiligo Treatment Market Analysis, Insights and Forecast, 2015-2026

    10.1. Key Findings / Summary

    10.2. Market Analysis – By Treatment

        10.2.1. Topical Treatment

        10.2.2. Light Therapy

        10.2.3. Surgical Procedures

        10.2.4. Others

    10.3. Market Analysis – By Disease Type

        10.3.1. Nonsegmental Vitiligo

        10.3.2. Segmental Vitiligo

    10.4. Market Analysis – By End-user

        10.4.1. Hospitals

        10.4.2. Aesthetic Clinics

        10.4.3. Others

    10.5. Market Analysis – By Country/Sub-region

        10.5.1. GCC Countries

        10.5.2. South Africa

        10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

    11.1. Key Industry Developments

    11.2. Global Market Share Analysis (2018)

    11.3. Competition Dashboard

    11.4. Comparative Analysis – Major Players

    11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))

        11.5.1. Incyte Corporation

        11.5.2. Astellas Pharma Inc.

        11.5.3. Bausch Health Companies Inc.

        11.5.4. Baxter International Inc.

        11.5.5. Dr. Reddy’s Laboratories Ltd.

        11.5.6. Pfizer Inc.

        11.5.7. STRATA Skin Sciences

12. Strategic Recommendation

  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Consulting Services
    How will you benefit from our consulting services ?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann